- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · May 15, 2024 | 11.78M sh |
| Short Term Investments | Q3 2024 · Mar 31, 2024 | $24.73M |
| Short Term Investments | Q3 2024 · Jun 30, 2023 | $26.73M |
| Cash And Equivalents | Q3 2024 · Mar 31, 2024 | $7M |
| Cash And Equivalents | Q3 2024 · Jun 30, 2023 | $12.24M |
| Stockholders Equity | Q3 2024 · Mar 31, 2024 | $36.86M |
| Stockholders Equity | Q3 2024 · Jun 30, 2023 | $38.93M |
| Current Liabilities | Q3 2024 · Mar 31, 2024 | $10.45M |
| Current Liabilities | Q3 2024 · Jun 30, 2023 | $16.51M |
| Total Liabilities | Q3 2024 · Mar 31, 2024 | $11.77M |
| Total Liabilities | Q3 2024 · Jun 30, 2023 | $16.51M |
| Current Assets | Q3 2024 · Mar 31, 2024 | $43.55M |
| Current Assets | Q3 2024 · Jun 30, 2023 | $51.86M |
| Total Assets | Q3 2024 · Mar 31, 2024 | $50.02M |
| Total Assets | Q3 2024 · Jun 30, 2023 | $56.93M |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 11.78M sh |
| Shares Diluted | Q3 2024 · Mar 31, 2023 | 11.72M sh |
| Capex | Q3 2024 · Mar 31, 2023 | $45.21K |
| Operating Cash Flow restated | Q3 2024 · Mar 31, 2023 | −$6.95M |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | $0.02 |
| Eps Diluted | Q3 2024 · Mar 31, 2023 | −$0.11 |
| Eps Basic | Q3 2024 · Mar 31, 2023 | $0.02 |
| Eps Basic | Q3 2024 · Mar 31, 2023 | −$0.11 |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $1.46M |
| Sga Expense | Q3 2024 · Mar 31, 2023 | $4.04M |
| Rd Expense | Q3 2024 · Mar 31, 2023 | $1.05M |
| Rd Expense | Q3 2024 · Mar 31, 2023 | $3M |
| Net Income | Q3 2024 · Mar 31, 2023 | $247.63K |
| Net Income | Q3 2024 · Mar 31, 2023 | −$1.26M |
| Net Income | Q3 2024 · Dec 31, 2022 | −$1.51M |
| Operating Income | Q3 2024 · Mar 31, 2023 | −$470.6K |
| Operating Income | Q3 2024 · Mar 31, 2023 | −$2.45M |
| Gross Profit | Q3 2024 · Mar 31, 2023 | $2.05M |
| Gross Profit | Q3 2024 · Mar 31, 2023 | $4.59M |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $9.81M |
| Cost Of Revenue | Q3 2024 · Mar 31, 2023 | $24.36M |